SCHEMBL6843380

SCHEMBL6843380

O=C(O)c1ccc(Cc2cc3cc(C(=O)OCc4ccc(Cl)cc4)ccc3cc2O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 3/20 0.48
ALDH1A1 P00352 4/20 0.44
NPSR1 Q6W5P4 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
MAPT P10636 3/20 0.43
MRGPRX4 Q96LA9 2/20 0.42
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42
RXRG P48443 1/20 0.42
GAA P10253 1/20 0.41
ALOX5 P09917 1/20 0.41
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6192360 0.91 LMNA (0.50) NR4A2ALDH1A1KMT2AMEN1MAPT
SCHEMBL6192665 0.90 NR4A2 (0.49) NR4A2KMT2AMEN1MAPTRXRA
SCHEMBL6842933 0.89 RXRA (0.48) ALDH1A1L3MBTL1KMT2AMEN1MAPT
SCHEMBL6843466 0.89 RXRA (0.48) NR4A2ALDH1A1KMT2AMEN1MAPT
SCHEMBL6192387 0.88 KMT2A (0.43) CYP3A4KMT2AMEN1MAPTNPC1
SCHEMBL6193256 0.88 NPC1 (0.50) ALDH1A1KMT2AMEN1MAPTRXRA
SCHEMBL6843461 0.86 CA1 (0.50) CYP2C19
SCHEMBL6843227 0.86 CA1 (0.39) ALDH1A1KMT2AMEN1MAPTNPC1
SCHEMBL6843196 0.86 NPC1 (0.41) NR4A2ALDH1A1KMT2AMEN1MAPT
SCHEMBL6842923 0.85 CA1 (0.41) ALDH1A1KMT2AMEN1MAPTRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040043983-A1 Naphthalene derivatives as matrix metalloproteinase inhibitors LI JIE JACK (US) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040043983-A1 Naphthalene derivatives as matrix metalloproteinase inhibitors MMP9, MMP8, MMP13 NR4A2 2222/4885ALDH1A1 1588/4885NPSR1 1783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.